Detalhe da pesquisa
1.
Comparison of Hospital Volume and Risk-Standardized Mortality Rate as a Proxy for Hospital Quality in Complex Oncologic Hepatopancreatobiliary Surgery.
Ann Surg Oncol
; 2024 May 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38700800
2.
Outcomes of Hepatic Artery-Based Therapies and Systemic Multiagent Chemotherapy in Unresectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis.
Ann Surg Oncol
; 2024 Mar 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38502296
3.
Surgical Resection Alone is Associated With Higher Long-Term Survival Than Multiagent Chemotherapy Alone for Patients With Localized Biliary Tract Cancers.
J Surg Res
; 295: 705-716, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38141457
4.
Understanding surgical attrition for "resectable" pancreatic cancer.
HPB (Oxford)
; 26(3): 370-378, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38042732
5.
Assessing the use of Extended Venous Thromboembolism Prophylaxis on the Rates of Venous Thromboembolism and Postpancreatectomy Hemorrhage Following Pancreatectomy for Malignancy.
Ann Surg
; 278(1): e80-e86, 2023 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35797622
6.
Why the Treatment Sequence Matters: Interplay Between Chemotherapy Cycles Received, Cumulative Dose Intensity, and Survival in Resected Early-stage Pancreas Cancer.
Ann Surg
; 278(4): e677-e684, 2023 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37071769
7.
Discordance Between Conventional and Detailed Lymph Node Analysis in Resected, Node-negative Pancreatic or Ampullary Adenocarcinomas and Association With Adverse Survival Outcomes: A Single-institution Analysis.
Ann Surg
; 278(6): e1204-e1209, 2023 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37051926
8.
Understanding Factors Leading to Surgical Attrition for "Resectable" Gastric Cancer.
Ann Surg Oncol
; 30(7): 4207-4216, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046129
9.
Trends in and Prognostic Significance of Time to Treatment in Pancreatic Cancer: A Population-Based Study.
Ann Surg Oncol
; 30(13): 8610-8620, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37624518
10.
Predictors of sentinel lymph node metastasis in very thin invasive melanomas.
Br J Dermatol
; 189(4): 419-426, 2023 09 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290803
11.
Management of adenocarcinoma of the pancreatic tail in the elderly.
J Surg Oncol
; 127(3): 405-412, 2023 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-36301227
12.
Disparities in guideline-compliant care for patients with pancreatic ductal adenocarcinoma at minority-versus non-minority-serving hospitals.
HPB (Oxford)
; 25(12): 1502-1512, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37558565
13.
Trends and disparities in the utilization of systemic chemotherapy in patients with metastatic hepato-pancreato-biliary cancers.
HPB (Oxford)
; 25(2): 239-251, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36411233
14.
The Role of the Microbiome in Gastroentero-Pancreatic Neuroendocrine Neoplasms (GEP-NENs).
Curr Issues Mol Biol
; 44(5): 2015-2028, 2022 Apr 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-35678665
15.
Weight Tracking as a Novel Prognostic Marker After Pancreatectomy.
Ann Surg Oncol
; 29(6): 3450-3459, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35067790
16.
Time to Neoadjuvant Chemotherapy Initiation Is not Associated With Survival in Pancreatic Cancer.
J Surg Res
; 276: 369-378, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35436663
17.
A comparison of robotic and laparoscopic minimally invasive adrenalectomy for adrenal malignancies.
Surg Endosc
; 36(7): 5374-5381, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34724582
18.
Facility type and size-stratified analysis of management patterns and outcomes of patients with localized non-functional pancreatic neuroendocrine tumors.
HPB (Oxford)
; 24(4): 498-506, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34419354
19.
Racial disparities in operative management of localized, non-functional pancreatic neuroendocrine tumors in surgically fit patients.
HPB (Oxford)
; 24(2): 217-225, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34247942
20.
Combined multiagent chemotherapy and radiotherapy is associated with prolonged overall survival in patients with non-operatively managed stage II-III pancreatic adenocarcinoma.
HPB (Oxford)
; 24(4): 433-442, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34465529